We Bring Latest and Current Updates
Taipei, The first solo exhibition in Taiwan of work by renowned Japanese artist Yoshitomo Nara, including his 2020 painting “Miss Moonlight,” is scheduled to open in Taipei on March 12, the organizer said in a …
Read MoreTaipei, The U.S. dollar rose against the Taiwan dollar Friday, gaining NT$0.013 to close at NT$28.480. Turnover totaled US$977 million during the trading session. The greenback opened at NT$28.250, and moved to a low of …
Read MoreTaipei, Shares in Taiwan ended lower Friday, falling below 16,000 on high turnover after the stock market hit a new record during the session. The weighted index on the Taiwan Stock Exchange (TWSE), or Taiex, …
Read MoreTaipei, The Central Epidemic Command Center (CECC) is planning to launch a public-private partnership to develop and produce antibody treatments against COVID-19, according to the National Health Research Institutes (NHRI). Speaking to the media on …
Read MoreJakarta, The Indonesian government will now require employers of Indonesian migrant workers and local governments in Indonesia to pay part of the workers’ placement fees starting on July 15 rather than Jan. 15 as previously …
Read MoreGAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP, FRAPS, to the position of Senior Vice President, Chief Regulatory and Quality Officer. In this newly created role, Dr. Ukwu will lead global […]
Read MoreDOVER, DE / ACCESSWIRE / January 14, 2021 / Pacific Green Technologies, Inc. (the “Company” or “PGTK,” (OTCQB:PGTK)) announces the signing of a Battery Energy Storage System Strategic Manufacturing Framework Agreement Memorandum of Understanding (the “Framework Agreement”) with Shanghai Electric Gotion New Energy Technology Co., Ltd. (“SEG”). Under the terms of the Framework Agreement, the […]
Read MoreGlow LifeTech has the exclusive rights for MyCell Technology™ in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC™, a COVID-19 Treatment Candidate with successful Phase II Clinical Results The formulation statistically significantly improved the clinical recovery of COVID-19 patients in the treatment group in comparison with placebo and […]
Read More